MEDICAL ADVOCATES
 IDUs
  Pregnant Women

Opiate Use and Pregnancy Outcomes
Addiction Management During Pregnancy
National Studies






 

 
IDU Main Page Main New/Newsworthy  Home Page

Last Update:  September 07, 2016

 Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader
Opiate Use and Pregnancy Outcomes
 
          Journal Papers, Abstracts, and Commentaries
 
  Obstetric and neonatal outcomes associated with maternal naltrexone exposure.
Hulse GK, O'Neill G, Pereira C, Brewer C
 Aust N Z J Obstet Gynaecol 2001 Nov;41(4):424-8
 Abstract
   
  FULL-TEXT ARTICLE
Transplacental transfer and metabolism of buprenorphine.
 Nanovskaya T, Deshmukh S, Brooks M, Ahmed MS.
 J Pharmacol Exp Ther 2002 n;300(1):26-33
Paper
   
  Neonatal outcome following maternal opiate use in late pregnancy.
Sinha C, Ohadike P, Carrick P, et al.
Int J Gynaecol Obstet 2001 Sep;74(3):241-6
 Abstract
   
  Postpartum risk factors in the development of children born to opiate-addicted mothers;
comparison between mothers with and without methadone substitution
Ziegler M, Poustka F, von Loewenich V, Englert E.
Nervenarzt 2000 Sep;71(9):730-6
 Abstract
Addiction Management During Pregnancy
Buprenorphine           Methadone                     Naltrexone

Buprenorphine
                    
          Journal Papers, Abstracts, and Commentaries        

  Pregnant opioid addicted patients and additional drug intake. Part I. Toxic effects and therapeutic consequences
Hoell I, Havemann-Reinecke U.
Med Monatsschr Pharm. 2011 Oct;34(10):363-74;
Abstract

Estimated Dose Exposure of the Neonate to Buprenorphine and Its Metabolite Norbuprenorphine via Breastmilk
During Maternal Buprenorphine Substitution Treatment.
Ilett KF, Hackett LP, Gower S, et al.
Breastfeed Med. 2011 Oct 19.
Abstract

Breast Feeding During Methadon- and Buprenorphin Therapy.
Müller MJ, Lange M, Paul T, Seeliger S.
 Klin Padiatr. 2011 Sep 26
Abstract

Oligodendrocyte responses to buprenorphine uncover novel and opposing roles of μ-opioid- and nociceptin/orphanin FQ
receptors in cell development: Implications for drug addiction treatment during pregnancy.
Eschenroeder AC, Vestal-Laborde AA, Sanchez ES, et al 
Glia. 2012 Jan;60(1):125-36.
Abstract

Buprenorphine in pregnancy
Eder H, Rupp I, Peternell A, Fischer G.et al.
Psychiatr Prax 2001 Sep;28(6):267-9
 Abstract

Methadone

          Journal Papers, Abstracts, and Commentaries 

  Breast Feeding During Methadon- and Buprenorphin Therapy.
Müller MJ, Lange M, Paul T, Seeliger S.
 Klin Padiatr. 2011 Sep 26
Abstract

Methadone and neonatal thrombocytosis.
Garcia-Algar O, Brichs LF, Garcia ES
Pediatr Hematol Oncol 2002 Apr-May;19(3):193-5
 Abstract		  

Naltrexone

          Journal Papers, Abstracts, and Commentaries  

  Obstetric and neonatal outcomes associated with maternal naltrexone exposure .
Hulse GK, O'Neill G, Pereira C, Brewer C.
Aust N Z J Obstet Gynaecol 2001 Nov;41(4):424-8
 Abstract
National Studies
Australia/Pacific Islands     Europe     North  America
Australia/Pacific Islands

Australia

        Journal Papers, Abstracts, and Commentaries

  The profile of substance-using pregnant mothers and their newborns at a regional
rural hospital in New South Wales.
Richardson R, Bolisetty S, Ingall C.
Aust N Z J Obstet Gynaecol 2001 Nov;41(4):415-9
 Abstract
Europe
 
Austria
 
        Journal Papers, Abstracts, and Commentaries
 
  Impact of treatment approach on maternal and neonatal outcome in pregnant opioid-maintained women.
Metz V, Jagsch R, Ebner N, et al
Hum Psychopharmacol. 2011 Aug 8.
 Abstract

Czech Republic

        Journal Papers, Abstracts, and Commentaries

  Characteristics of a population of drug dependent pregnant women in the Czech Republic
Vavrinkova B, Binder T, Zivny J., et al.
 Ceska Gynekol 2001 Jul;66(4):285-91
 Abstract
 
Norway
 
        Journal Papers, Abstracts, and Commentaries
 
  Risks and realities: Dyadic interaction between 6-month-old infants and their mothers in opioid maintenance treatment.
Sarfi M, Smith L, Waal H, Sundet JM.
Infant Behav Dev. 2011 Aug 7.
 Abstract
 
Latin America/Caribbean
 
Mexico
 
        Journal Papers, Abstracts, and Commentaries
 
  Assessing the extent of provision of comprehensive medical care management for female sexual assault patients in US hospital emergency departments.
Patel A, Roston A, Tilmon S,  et al
Int J Gynaecol Obstet. 2013 Jul 10.
 Abstract
 

North America
 
United States

         Journal Papers, Abstracts, and Commentaries
 
 
Intrauterine abstinence syndrome (IAS) during buprenorphine inductions and methadone tapers: can we assure the safety of the fetus?
McCarthy JJ.
J Matern Fetal Neonatal Med. 2011 Aug 25
 Abstract

Excretion of Methadone in Sweat of Pregnant Women Throughout Gestation After
Controlled Methadone Administration.
Barnes AJ, Brunet BR, Choo RE, et al
Ther Drug Monit. 2010 Jun 29
 Abstract
   
Russia/NIS

Russia
 
        Journal Papers, Abstracts, and Commentaries
 
  Association between Pregnancy and Active Injection Drug Use and Sex Work among Women Injection Drug Users in Saint Petersburg, Russia.
Girchenko P, Ompad DC, Bikmukhametov D, Gensburg L.
J Urban Health. 2015 Apr 3.
 Abstract

Contraception use and unplanned pregnancies among injection drug using women in
St Petersburg, Russia.
Abdala N, Kershaw T, Krasnoselskikh TV, Kozlov AP.
J Fam Plann Reprod Health Care. 2011 Apr 14
 Abstract
Ukraine
 
        Journal Papers, Abstracts, and Commentaries
 
 

Prevention of mother-to-child transmission of HIV among pregnant women using injecting drugs in Ukraine, 2000-2010.
Thorne C, Semenenko I, Malyuta  
Addiction. 2011 Aug 5
 Abstract

IDU Main Page Main New/Newsworthy  Home Page

IDU Health: Pregnancy